TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel TRITON-TIMI 38 AHA 2007 Orlando, Florida Disclosure Statement: The TRITON-TIMI…
TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel TRITON-TIMI 38 Elliott M. Antman, MD TRITON-TIMI 38 was supported by…